Treatment with LEDs at a wavelength of 642 nm enhances skin tumor proliferation in a mouse model

Photobiomodulation (PBM) is attracting increased attention in the fields of dermatology and cosmetics. PBM with a variety of light parameters has been used widely in skin care, but can cause certain types of unwanted cells to proliferate in the skin; this can lead to skin tumors, such as papillomas...

Full description

Saved in:
Bibliographic Details
Published inBiomedical optics express Vol. 12; no. 9; pp. 5583 - 5596
Main Authors Goo, Hyeyoon, Mo, SangJoon, Park, Hyeong Ju, Lee, Min Young, Ahn, Jin-Chul
Format Journal Article
LanguageEnglish
Published Optical Society of America 01.09.2021
Online AccessGet full text

Cover

More Information
Summary:Photobiomodulation (PBM) is attracting increased attention in the fields of dermatology and cosmetics. PBM with a variety of light parameters has been used widely in skin care, but can cause certain types of unwanted cells to proliferate in the skin; this can lead to skin tumors, such as papillomas and cancers. We constructed a mouse model of human skin tumors using DMBA as an initiator and TPA as a promoter, and confirmed that LEDs with a wavelength of 642 nm (red light) increased tumor size, epidermal thickness, and systemic proinflammatory cytokine levels. These results indicated that skin tumor cell proliferation may result from the use of 642 nm LEDs, suggesting the need for regulation of skin care based on LED light therapy.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:2156-7085
2156-7085
DOI:10.1364/BOE.427205